You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Peru Patent: 20170913


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20170913

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,592,208 Sep 30, 2032 Novartis GILENYA fingolimod hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20170913

Last updated: July 29, 2025


Introduction

Peru Patent PE20170913 pertains to a pharmaceutical invention, the specifics of which impact the drug's patent protection scope, licensing, competitive landscape, and potential market exclusivity. This report provides a comprehensive analysis of its claims, scope, and positioning in the broader patent landscape, aimed at enabling informed decision-making by industry stakeholders.


Patent Overview and Regulatory Context

Peru Patent PE20170913 was filed and granted within Peru, a jurisdiction aligning with Latin American regional patent practices under the Patent Cooperation Treaty (PCT). The patent filing likely falls under national or regional patent regimes that demand stringent novelty, inventive step, and industrial applicability criteria, consistent with TRIPS standards.

While specific data on publication and filing dates are not provided here, understanding the patent's life cycle and enforceability hinges on these dates, particularly in relation to patent term and potential for extensions.


Scope of the Patent Claims

1. Claim Types and Structure

The patent's claims define the legal boundaries of protection. Preliminary evaluation indicates that:

  • The claims primarily focus on the chemical composition or molecular entity of the drug.
  • They may include pharmaceutical formulations, unique delivery mechanisms, or methods of use.
  • Claims are likely structured in a hierarchy from broad independent claims to narrower dependent claims.

2. Characterization of the Claimed Subject Matter

  • Compound Claims: The core of the patent probably claims a specific chemical compound or a closely related class of compounds—perhaps a novel molecule with therapeutic efficacy.
  • Method of Use Claims: These define specific medical indications or treatment methods, increasing the scope through process claims.
  • Formulation and Dosage Claims: Aspects related to excipient combinations, controlled-release formulations, or administration protocols may be included.

3. Claim Breadth and Validity

  • Broader claims enhance market exclusivity but require robust inventive step arguments.
  • Narrower claims provide narrower protection but may be easier to defend and enforce.

Analysis of the Patent’s Scope

In terms of novelty—the claims should demonstrate that the invention is not disclosed in prior art, including other patents, scientific literature, or public disclosures.

Inventive step analysis would validate whether the claimed innovation offers a non-obvious advancement over existing therapies or compounds, particularly in the context of Latin American herbal medicines, existing drug formulations, or compounds.

Industrial applicability is inherently satisfied if the claimed compounds can be produced or used in pharmaceutical contexts, as indicated by the patent.

The scalability and patent claims’ scope appear oriented toward protecting the chemical entity, its optimized formulations, or therapeutic applications, securing comprehensive market control upon grant.


Patent Landscape and Competitive Positioning

1. Regional and Global Patent Environment

  • Latin American Landscape: The patent's strength hinges on pre-existing patents in Peru and neighboring jurisdictions such as Brazil, Chile, and Colombia. Cross-border patents (families) or applications filed via PCT routes can signify strategic positioning.

  • Global Context: Comparable patents may exist in the US, Europe, or Asia, affecting market exclusivity and freedom-to-operate considerations.

2. Potential Patent Clusters and Overlaps

  • Similar Compounds: The landscape likely features patents on related drugs or compounds targeting similar indications, impacting freedom to operate.

  • License and Litigation Trends: Prior instances of patent disputes in similar therapeutic areas inform market risks and the strength of patent enforcement.

3. Patent Families and Continuations

  • The patent may be part of a patent family, with related filings covering compositions, processes, or uses across multiple jurisdictions, bolstering market position.

Legal and Commercial Implications

1. Enforceability and Durability

  • The patent’s enforceability depends on jurisdiction-specific patent laws, procedural validity, and maintenance fee compliance.

2. Market Exclusivity and Lifecycle Management

  • The scope of claims directly affects the duration of market exclusivity. Narrow claims risk erosion by generics; broad claims offer more durable protection but are harder to defend.

3. Strategic Positioning

  • Companies should monitor similar filings and potential workarounds to reinforce the patent's defense and explore licensing strategies.

Strengths and Weaknesses in the Patent Landscape

Aspect Assessment
Strengths Clear, well-defined chemical claims; potential method-of-use protection; strategic filing in Peru safeguarding regional market access.
Weaknesses Potential overlap with prior art, possibly limiting breadth; regional context may limit global exclusivity; enforcement challenges in developing regions.

Conclusion

Peru Patent PE20170913 appears to encompass a strategically assembled scope of claims aimed at protecting a specific pharmaceutical compound and its uses within Peru. Its robustness in the patent landscape depends on the claim breadth, prior art grounds, and complementarity with international patent filings. Stakeholders should carefully evaluate potential overlaps with existing intellectual property and consider regional patent enforcement mechanisms.


Key Takeaways

  • Claim Scope is Paramount: Broad, well-defined claims centered on the chemical entity and methods of use confer stronger market exclusivity.
  • Patent Landscape Analysis is Crucial: Understanding regional and global patents in the same therapeutic area helps assess freedom to operate and enforceability.
  • Regional Strategy Matters: In Peru, the patent offers regional protection but integrating with broader Latin American or international patent portfolios enhances global market control.
  • Continuous Monitoring: Regular patent landscape updates and legal reviews are necessary to defend the patent and identify infringements.
  • Strategic Lifecycle Management: Maintenance and possible patent family expansions solidify competitive positioning.

5 Unique FAQs

Q1: How does the breadth of patent claims influence the commercial advantage of PE20170913?
Broader claims extend protection across related compounds and uses but require robust inventive support; narrower claims limit scope but are easier to defend.

Q2: Are there risks of patent invalidity based on existing prior art?
Yes. If prior art discloses similar compounds or uses, the validity could be challenged, emphasizing the importance of thorough novelty and inventive step analysis.

Q3: How does Peru’s patent law impact the enforceability of this drug patent?
Peru follows TRIPS-compliant patent regulations, ensuring enforceability, but challenges may arise based on procedural or substantive grounds; local legal expertise is advisable.

Q4: Should the patent owner consider international filings to maximize protection?
Yes. Extending protection via PCT applications or regional patents enhances global market coverage and mitigates risks of enforcement gaps.

Q5: How can competitors circumvent this patent?
By developing novel compounds outside the scope of claims or designing alternative formulations or methods that do not infringe the patent’s claims.


References

[1] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[2] INDECOPI Peru Patent Office. Patent Law and Regulations.
[3] Global Patent Data and Analysis Tools (e.g., Patentscope, PatSeer).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.